Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 24, 2024 09:45 ET | Source: Research and Markets

Trauma Care Centers Market Projected to Reach USD 26 Billion by 2030 Driven by Advancements in Emergency Services & Rehabilitation

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Trauma Care Centers Market by Facility (In-house, Standalone), Service (Inpatient, Outpatient, Rehabilitation), Trauma - Forecast 2024-2030"...
July 06, 2023 08:00 ET | Source: electroCore, Inc.

gammaCore™ Non-Invasive Vagal Nerve Stimulation Selected for Study Funded by the National Football League (NFL) and National Football League Players Association (NFLPA) on Alleviating Concussion Symptoms

ROCKAWAY, N.J., July 06, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that its gammaCore non-invasive...
May 11, 2023 12:00 ET | Source: Neuronic Devices Operations GmbH

Neuronic and Santa Clara University partner to develop next-gen neurotech for photobiomodulation guided by real-time brain activity

Integrating photobiomodulation with neurofeedback will revolutionize treatment of brain disorders SANTA CLARA, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- Neuronic, a multi-national company focused...
April 26, 2023 08:00 ET | Source: electroCore, Inc.

National Institutes of Health Awards Grant for Pivotal Clinical Trial of gammaCore™ (nVNS) in Patients with Opioid Use Disorders

ROCKAWAY, N.J., April 26, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that the National Institute on...
April 24, 2023 08:00 ET | Source: electroCore, Inc.

Study Presented at 75th Annual Meeting of the American Academy of Neurology Demonstrates that gammaCore (nVNS) Can Accelerate Foreign Language Learning

ROCKAWAY, N.J., April 24, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that the Air Force Research...
April 06, 2023 08:00 ET | Source: electroCore, Inc.

electroCore, Inc. Announces Product Registration in Indonesia, Malaysia and South Africa

ROCKAWAY, N.J., April 06, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the receipt of a...
April 04, 2023 08:00 ET | Source: electroCore, Inc.

electroCore, Inc. Announces gammaCore Non-Invasive Vagus Nerve Stimulator Available Through the Carrick Institute

ROCKAWAY, N.J., April 04, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that the...
March 23, 2023 08:00 ET | Source: electroCore, Inc.

electroCore Reports Results of Pre-Clinical Trial in a Model of Traumatic Brain Injury

ROCKAWAY, N.J., March 23, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the publication of a paper...
March 21, 2023 08:00 ET | Source: electroCore, Inc.

electroCore's Truvaga Users Reported Improved Stress, Anxiety, Sleep, Energy and Mood in Recent Focus Group Study

ROCKAWAY, N.J., March 21, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the results of a...
March 14, 2023 08:30 ET | Source: electroCore, Inc.

electroCore Affirms No Direct Exposure to Silicon Valley Bank, Silvergate Bank, or Signature Bank

ROCKAWAY, N.J., March 14, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today it does not have direct exposure...

Next Page keyboard_arrow_right